Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 448 followers

Latest posts

Last updated about 5 hours ago

Innovation Task Force (ITF) briefing meeting request form

about 9 hours ago

Innovation Task Force (ITF) briefing meeting request form

PSUSA/00000732/202512

about 12 hours ago

PSUSA/00000732/202512

PSUSA/00001088/202512

about 12 hours ago

PSUSA/00001088/202512

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation...

Electronic product information (ePI)

about 15 hours ago

Electronic product information (ePI)

PSUSA/00011041/202510

about 16 hours ago

PSUSA/00011041/202510

How to pay

about 16 hours ago

How to pay

How to pay fees and charges levied by EMA: Guidance to marketing authorisation holders and applicants

about 16 hours ago

How to pay fees and charges levied by EMA: Guidance to marketing...

SEPA Direct Debit B2B: Guidance for marketing authorisation holders and applicants

about 16 hours ago

SEPA Direct Debit B2B: Guidance for marketing authorisation holders and applicants

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation...

Tackling antimicrobial resistance: Information for animal health practitioners

1 day ago

Tackling antimicrobial resistance: Information for animal health practitioners

Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 4, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation...